Male recipients of BNT162b2 developed IgG anti-spike avidity levels that tended to be lower than females that received the same vaccine; however, the difference did not reach statistical significance (p = .0607).
← all excerpts
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines.
1
0.0607
0.0607